Trial intelligence / Profile preview

In vivo characterization of allergen extracts

NL-OMON35402Active, not recruiting

Sponsor: HAL Allergy Group
Start: Apr 2010
Countries: 1

Overview

Open-label, single-arm trial in allergy, sponsored by HAL Allergy Group. Primary endpoints: Sum of erythema diameters at 20 minutes after intracutaneous injection and Calculated biological allergy units. Started Apr 2010; status: active, not recruiting.

Conditions

allergy

Beyond the preview

Go deeper on NL-OMON35402.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35402.